Skip to content
DataLookout
Menu

ALICANCT06467175

The Benefits of Long-read High-throughput Genomic Sequencing for the Causal Diagnosis of Cerebellar Ataxias

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 1 year 5 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Jun 2028 to Dec 2029
    • Eligibility criteria expanded, about 10 words
    • Primary endpoints: details revised at 1 of 1 entry
  2. Notable Primary and study completion dates: Mar 2027 to Jun 2028v3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2024 to Dec 11, 2024
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Identification of a causal genetic variant (class 4 or 5 variant - ACMG classification) that may explain the patients' symptoms.
Timeframe: Through study completion, on average of 18 months

Arms and interventions

cax index with 1 to 2 relativesExperimental

Biologicals: blood sampling for high molecular weight DNA extraction

Sites

1 site in 1 country

  • Chu Dijon BourgogneDijon, France